NewsDesk @bactiman63 The Florida Department of Health (FDOH) is reporting an outbreak of meningococcal disease in 2022, primarily among gay, bisexual, and other men who have sex with men, including those...

NewsDesk @bactiman63 The Finland National Institute for Health and Welfare (THL) recommends that municipalities provide a fourth dose of coronavirus vaccine to those over 80 years of age and to all seniors...

NewsDesk @bactiman63 A potential vaccine developed by University of Guelph researchers to combat one of the main causes of bacterial diarrheal illness worldwide is set to be tested on people early this...

NewsDesk @bactiman63 The “61st National Oral Polio Vaccination Campaign” begins next Monday, March 14, in Cuba. All children from one month of age and up to two years, 11 months and 29 days...

NewsDesk @bactiman63 Moderna Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Monday signed a memorandum of understanding with the Kenyan government to establish...

NewsDesk @bactiman63 The Poland Ministry of Health reported Friday in response to the increased crossing of borders by people of Ukrainian nationality, in connection with the armed conflict on the territory...

NewsDesk @bactiman63 The World Health Organization (WHO) announced Friday the recommendations for the viral composition of influenza vaccines for the 2022-2023 influenza season in the northern hemisphere. The...

NewsDesk @bactiman63 The Swedish Public Health Agency recommends a second booster dose of COVID-19 vaccine to people who live at SÄBO (Special housing for the elderly), have home care or home health...

NewsDesk @bactiman63 Data from two CDC reports Friday show COVID-19 vaccine boosters remain safe and continue to be highly effective against severe disease over time. In the first study, CDC reviewed...

NewsDesk @bactiman63 Cambridge, Massachusetts company, Public Health Vaccines, LLC announced today the start of its Phase 1 clinical trial to evaluate the safety and immunogenicity of the company’s...